Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
-
2023 SS
-
2022 WS
-
2022 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer typesIn: Biochemical and Biophysical Research Communications (BBRC) Jg. 500 (2018) Nr. 3, S. 621 - 625Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tagsIn: Biomarkers Jg. 22 (2017) Nr. 2, S. 113 - 122Online Volltext: dx.doi.org/
-
Tumor response assessment : comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteriaIn: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 12, S. 2527 - 2533Online Volltext: dx.doi.org/
-
Circulating Tumor Cell Composition in Renal Cell CarcinomaIn: PLoS ONE Jg. 11 (2016) Nr. 4, e0153018Online Volltext: dx.doi.org/ (Open Access)
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsIn: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805Online Volltext: dx.doi.org/
-
Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infectionIn: Journal of Viral Hepatitis Jg. 23 (2016) Nr. 5, S. 375 - 386Online Volltext: dx.doi.org/
-
Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesionsIn: Journal of Clinical Pathology: JCP Online Jg. 69 (2016) Nr. 7, S. 619 - 626Online Volltext: dx.doi.org/
-
Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular CarcinomaIn: Journal of Proteome Research Jg. 15 (2016) Nr. 1, S. 38 - 47Online Volltext: dx.doi.org/
-
A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumorsIn: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Jg. 1854 (2015) Nr. 6, S. 641 - 650Online Volltext: dx.doi.org/
-
Analysis of disease-associated protein expression using quantitative proteomics : fibulin-5 is expressed in association with hepatic fibrosisIn: Journal of Proteome Research Jg. 14 (2015) Nr. 5, S. 2278 - 2286Online Volltext: dx.doi.org/
-
Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomasIn: Pathology Jg. 47 (2015) Nr. 6, S. 543 - 550Online Volltext: dx.doi.org/
-
A practical data processing workflow for multi-OMICS projectsIn: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Jg. 1844 (2014) Nr. 1 Part A, S. 52 - 62Online Volltext: dx.doi.org/ (Open Access)
-
Circulating tumor cell composition and outcome in patients with solid tumorsIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 52 (2014) Nr. 1, S. 74 - 75Online Volltext: dx.doi.org/
-
Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)In: PLoS ONE Jg. 9 (2014) Nr. 12, e113706Online Volltext: dx.doi.org/ (Open Access)
-
Hepatocellular cancer : New kids on the blockIn: Gastrointestinal Tumors Jg. 1 (2014) Nr. 4, S. 195 - 200Online Volltext: dx.doi.org/
-
IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinomaIn: Biomarkers in Medicine Jg. 8 (2014) Nr. 5, S. 687 - 698Online Volltext: dx.doi.org/
-
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinomaIn: Molecular and Cellular Proteomics (MCP) Jg. 13 (2014) Nr. 10, S. 2661 - 2672Online Volltext: dx.doi.org/
-
Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatmentIn: Translational Lung Cancer Research Jg. 3 (2014) Nr. 2, S. 100 - 106Online Volltext: dx.doi.org/ (Open Access)
-
Role of circulating tumor cells and cancer stem cells in hepatocellular carcinomaIn: Hepatology International Jg. 8 (2014) Nr. 3, S. 321 - 329Online Volltext: dx.doi.org/
-
EGFR, FLT1 and Heparanase as Markers Identifying Patients at Risk of Short Survival in CholangiocarcinomaIn: PLoS ONE Jg. 8 (2013) Nr. 5, 0064186Online Volltext: dx.doi.org/ (Open Access)
-
Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatmentIn: British Journal of Cancer (BJC) Jg. 109 (2013) Nr. 5, S. 1223 - 1229Online Volltext: dx.doi.org/ (Open Access)
-
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signatureIn: PLoS ONE Jg. 8 (2013) Nr. 1, e54193Online Volltext: dx.doi.org/ (Open Access)
-
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinomaIn: Translational Oncology Jg. 6 (2013) Nr. 4, S. 420 - 428Online Volltext: dx.doi.org/
-
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics studyIn: Molecular and Cellular Proteomics (MCP) Jg. 12 (2013) Nr. 7, S. 2006 - 2020Online Volltext: dx.doi.org/
-
Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexedIn: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 4, S. 766 - 767Online Volltext: dx.doi.org/ (Open Access)
-
Zug um Zug : Tumorzellen in Schach halten – Moderne Konzepte zur Behandlung des LungenkarzinomsIn: Unikate: Berichte aus Forschung und Lehre (2012) Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 90 - 97Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
High-risk PCI in acute coronary syndromes with Impella LP 2.5 device supportIn: International Journal of Cardiology Jg. 153 (2011) Nr. 1, S. 59 - 63Online Volltext: dx.doi.org/
-
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapyIn: Neoplasia: An International Journal for Oncology Research Jg. 12 (2010) Nr. 8, S. 628 - 636Online Volltext: dx.doi.org/ (Open Access)
-
Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinomaIn: Pharmacogenomics Jg. 11 (2010) Nr. 3, S. 341 - 347Online Volltext: dx.doi.org/
-
A three-gene signature for outcome in soft tissue sarcoma.In: Clinical Cancer Research Jg. 15 (2009) Nr. 16, S. 5191 - 5198Online Volltext: dx.doi.org/ Online Volltext
-
Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 109 - 110Online Volltext: dx.doi.org/ (Open Access) -
Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 108Online Volltext: dx.doi.org/ (Open Access) -
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227Online Volltext: dx.doi.org/ -
Circulating tumor cell composition and molecular markers in metastasized renal cell carcinoma (mRCC)
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 131Online Volltext: dx.doi.org/ -
Circulating tumor cell subgroups and outcome in patients with non-small-cell-lung-cancer receiving platinum based treatment
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89Online Volltext: dx.doi.org/ -
Correlation of proteomics and first-line platinum-based chemotherapy in stage NSCLC in a large single-center cohort
50th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, 2014, Chicago, Illinois, USA,In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl.,Online Volltext: dx.doi.org/ -
Detection of circulating tumor cell sub-populations in patients with head and neck squamous cell carcinoma (HNSCC)
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 77 - 78Online Volltext: dx.doi.org/ -
Presence of circulating tumor cells with stem cell characteristics predicts response to SIRT in hepatocellular carcinoma
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 53Online Volltext: dx.doi.org/ -
A novel method for the detection of different subgroups of circulating tumor cells in patients with hepatocellular carcinoma
63rd Annual Meeting of the American Association for the Study of Liver Diseases, The Liver Meeting 2012, November 9-13, 2012, Boston, Mass., USA,In: Hepatology Jg. 56 (2012) Nr. Suppl. 1, S. 457AOnline Volltext: dx.doi.org/ -
An investigator-initiated monocentric phase I dose escalation trial of temsirolimus and irinotecan (TEMIR) in patients with relapsing glioblastoma multiforme (reGBM)
48th Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1-5, 2012, Chicago, Ill., USA,In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. 15, Suppl., 2086Online Volltext: dx.doi.org/ -
Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S376 - S377 -
VEGF receptor 1 and heparanase expression as prognostic factors in cholangiocellular carcinomaIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 4, Suppl., S. 226Online Volltext: dx.doi.org/
-
Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancer
2010 ASCO Annual Meeting, June 4-8, 2010, Chicago, Ill., USA,In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 15, Suppl., 7512 -
Entwicklung genetischer Signaturen für personalisierte Therapieentscheidungen bei Patienten mit soliden TumorenDuisburg, Essen (2011) 1 CD-ROM
-
A panel of mass spectrometry based serum protein tests for predicting graft-versus-host disease (GvHD) and its severity
106th Annual Meeting of the American Association for Cancer Research (AACR), April 18-22, 2015, Philadelphia, PA, USA,In: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. 599Online Volltext: dx.doi.org/ -
MicroRNA profiling and cisplatin–DNA interactions in an isogenic model of cisplatin resistant NSCLC cell lines
11th Annual British Thoracic Oncology Group Conference, 23-25 January 2013, Dublin, Ireland,In: Lung Cancer Jg. 79 (2013) Nr. Suppl. 1, S. S1Online Volltext: dx.doi.org/ -
Pre-therapeutic ex-vivo repair kinetics of cisplatin-DNA-adducts in circulating tumor cells (CTC) as platinum resistance test
11th Annual British Thoracic Oncology Group Conference, 23-25 January 2013, Dublin, Ireland,In: Lung Cancer Jg. 79 (2013) Nr. Suppl. 1, S. S2Online Volltext: dx.doi.org/ -
Microrna profiling and CDDP-GPG dna adduct formation analysis in a panel of cisplatin resistant non-small cell lung cancer cell lines
37th ESMO Congress, 28 September - 2 October 2012, Vienna, Austria,In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. ix68Online Volltext: dx.doi.org/ -
Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S1114 -
Register trial of sorafenib (S) for patients (pts) with metastatic uveal melanoma (metUvMel)
EORTC – NCI – ASCO Annual Meeting on ‘Molecular Markers in Cancer’, 27-29 October 2011, Brussels, Belgium,In: European Journal of Cancer (EJC) Jg. 47 (2011) Nr. Suppl. 4, S. S30Online Volltext: dx.doi.org/ -
Interpatient pharmacokinetic variability of 5-FU within metastatic and adjuvant colon cancer patients : First results from the West German Cancer Center
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 173Online Volltext: dx.doi.org/